Fikrettin Sahin

This inventor holds 26 USPTO granted patents and 25 published patent applications and 14 EPO patents, primarily in Biomedical Innovations. Top assignee: Yeditepe Üniversitesi. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fikrettin Sahin. Retrieved from https://idiyas.com/inventor/fikrettin-sahin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 25)

% Patents Active = 84.6

EPO Patents = 14 (Patent Applications = 33)

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 7(Granted Patents)

Company Filing History:

26 out of 44

Yeditepe Üniversitesi

patents

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Endometriosis Diagnosis

Plant Exosomes

Cancer Treatment

Stem Cell Differentiation

Antimicrobial Coatings

Wound Healing

Obesity Treatment

Nanoparticles

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12699103 - Biological markers in the diagnosis of endometriosis (2026-08-04),

2. 12642758 - Use of plant exosomes for enhancing viability and hair growth capacity of skin cells (2026-06-02),

3. 12590289 - Medium-based method realized for differentiation of dental stem cells into neurons (2026-03-31),

4. 12522566 - 2-(3-(2-methyl-6-(p-tolyl) pyridine-3-yl) ureido) benzenesulfonamide and derivatives as inhibitor of carbonic anhydrase IX for the treatment of cancer (2026-01-13),

5. 12521413 - Molecular basis of fatty liver inhibition by sodium borates (2026-01-13),

6. 12514890 - Plant exosomes used for treatment of diseases originating from protein aggregates formed in cells (2026-01-06),

7. 12465623 - Use of parasites and extracellular vesicles obtained from parasites in cancer treatment (2025-11-11),

8. 12329777 - Use of mutant P53 gene targeted lead borate nanoparticles in cancer treatment and production method of these nanoparticles (2025-06-17),

9. 12208117 - Glycerol and sodium pentaborate based formulation preventing postoperative adhesions (2025-01-28),

10. 12139415 - Use of nano-sized lanthanide borate (dysprosium borate and erbium borate) compounds for wound healing purposes and production method thereof (2024-11-12),

11. 12138235 - Cape-loaded targeted microvesicular cancer drug and method for developing the same (2024-11-12),

12. 12129384 - Pectin based antimicrobial surface coating material (2024-10-29),

13. 11638719 - Product for obesity treatment (2023-05-02),

14. 11578229 - Gelatin or pectin based antimicrobial surface coating material (2023-02-14),

15. 11510943 - Chemotherapeutic agent comprising combination of alexidine dihydrochloride and sodium pentaborate pentahydrate (2022-11-29),

Title: The Innovative Contributions of Fikrettin Sahin

Introduction

Fikrettin Sahin is a prominent inventor based in Istanbul, Turkey, with an impressive portfolio comprising 18 patents. His inventive contributions are significant in the field of medical formulations, addressing crucial challenges in postoperative care and wound healing.

Latest Patents

Sahin's latest patents showcase his innovative approach to preventing complications in medical procedures. One notable patent is a glycerol and sodium pentaborate based formulation designed to prevent postoperative adhesions between manipulated tissues and organs. This formulation utilizes glycerol, a widely available biomolecule in the human body, combined with sodium pentaborate, known for its positive effects on wound healing.

Another remarkable invention is the use of nano-sized lanthanide borate compounds (specifically erbium borate and dysprosium borate) for wound healing applications. This patent discusses the synthesis of these compounds using a buffered-precipitation method at room temperature, emphasizing their significant efficacy in promoting cell healing during biological applications.

Career Highlights

Throughout his career, Fikrettin Sahin has held positions that leverage his expertise in the field of biomedical innovations. Notably, he has worked at Yeditepe University, contributing to research and development initiatives. His work showcases a commitment to advancing knowledge and applications in the medical field.

Collaborations

Sahin's innovative journey includes collaborations with accomplished researchers such as Okan Demir and Selami Demirci. These partnerships have been pivotal in enhancing the breadth and impact of his inventions, fostering a collaborative spirit within the research community.

Conclusion

Fikrettin Sahin stands out as an influential inventor whose contributions are reshaping the landscape of medical formulations. With a focus on reducing postoperative complications and enhancing wound healing, his work exemplifies the critical role of innovation in improving patient care. As he continues to pursue groundbreaking inventions, his legacy in the field of medical technology is sure to grow.

Profile summary based on public USPTO records.